SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 87 filers reported holding SUTRO BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $457,346 | +0.6% | 98,354 | 0.0% | 0.02% | +5.9% |
Q1 2023 | $454,395 | -61.9% | 98,354 | -33.3% | 0.02% | -62.2% |
Q4 2022 | $1,192,050 | +31.0% | 147,531 | -10.0% | 0.04% | +21.6% |
Q3 2022 | $910,000 | +6.6% | 163,924 | 0.0% | 0.04% | +8.8% |
Q2 2022 | $854,000 | -36.6% | 163,924 | 0.0% | 0.03% | -27.7% |
Q1 2022 | $1,347,000 | -72.4% | 163,924 | -50.0% | 0.05% | -70.1% |
Q4 2021 | $4,878,000 | -35.5% | 327,850 | -18.1% | 0.16% | -35.4% |
Q3 2021 | $7,559,000 | +1.6% | 400,147 | 0.0% | 0.24% | +0.4% |
Q2 2021 | $7,439,000 | -43.0% | 400,147 | -30.3% | 0.24% | -46.1% |
Q1 2021 | $13,060,000 | -14.4% | 573,823 | -18.3% | 0.45% | -16.2% |
Q4 2020 | $15,252,000 | +136.6% | 702,523 | +9.6% | 0.54% | +121.5% |
Q3 2020 | $6,445,000 | +29.5% | 641,268 | 0.0% | 0.24% | +28.0% |
Q2 2020 | $4,976,000 | -23.9% | 641,268 | 0.0% | 0.19% | -36.1% |
Q1 2020 | $6,541,000 | -7.3% | 641,268 | 0.0% | 0.30% | +10.9% |
Q4 2019 | $7,054,000 | +21.0% | 641,268 | 0.0% | 0.27% | +5.1% |
Q3 2019 | $5,829,000 | -20.1% | 641,268 | 0.0% | 0.25% | -14.8% |
Q2 2019 | $7,298,000 | -0.1% | 641,268 | 0.0% | 0.30% | +0.3% |
Q1 2019 | $7,304,000 | +252.2% | 641,268 | +178.9% | 0.30% | +233.7% |
Q4 2018 | $2,074,000 | -44.7% | 229,900 | -8.0% | 0.09% | -34.6% |
Q3 2018 | $3,750,000 | – | 250,000 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |